Bee Thin: Public Notification - Undeclared Drug Ingredient
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. (Source: FDA MedWatch)
Source: FDA MedWatch - November 24, 2014 Category: American Health Source Type: news

Black Storm: Public Notification - Undeclared Drug Ingredient
Sildenafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. (Source: FDA MedWatch)
Source: FDA MedWatch - November 24, 2014 Category: American Health Source Type: news

Bee Slim: Public Notification - Undeclared Drug Ingredient
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. (Source: FDA MedWatch)
Source: FDA MedWatch - November 24, 2014 Category: American Health Source Type: news

Gabapentin Capsules, USP 300 mg, by Aurobindo Pharma USA: Recall - Complaints of Empty Capsules
Risk of missed dose(s) resulting in no effect, short term reduction in efficacy, short term withdrawal effect, or status epilepticus (long period seizures) that could be life-threatening. (Source: FDA MedWatch)
Source: FDA MedWatch - November 24, 2014 Category: American Health Source Type: news

Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled Overpouch
Administration of a dose lower than intended, especially in patients prone to severe electrolyte imbalance, may lead to serious, life-threatening adverse health consequences. (Source: FDA MedWatch)
Source: FDA MedWatch - November 21, 2014 Category: American Health Source Type: news

Forever Beautiful Bee Pollen by REFA Enterprises: Recall - Undeclared Drug Ingredients
Risk for those with a history of coronary artery disease, congestive heart failure, arrhymias or stroke (Source: FDA MedWatch)
Source: FDA MedWatch - November 20, 2014 Category: American Health Source Type: news

Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur
Failure of power supply may cause ventilator to shut off, resulting in too much carbon dioxide or not enough oxygen in patient’s blood, or death. (Source: FDA MedWatch)
Source: FDA MedWatch - November 19, 2014 Category: American Health Source Type: news

ABC Dophilus Powder by Solgar, Inc: Recall - Risk of Infection
The product was found to contain Rhizopus oryzae, which may cause health problems to consumers, particularly premature infants/infants, children, and those with weakened immune systems. (Source: FDA MedWatch)
Source: FDA MedWatch - November 17, 2014 Category: American Health Source Type: news

Long-term Antiplatelet Therapy: Safety Announcement - Preliminary Trial Data Shows Benefits But a Higher Risk of Non-Cardiovascular Death
FDA believes the benefits of clopidogrel (Plavix) and prasugrel (Effient) therapy continue to outweigh their potential risks when used for approved uses. (Source: FDA MedWatch)
Source: FDA MedWatch - November 16, 2014 Category: American Health Source Type: news

Gel-E Donut and Squishon 2 Products by Children’s Medical Ventures: Recall - Potential Mold Contamination
There is the possibility of fungal infection should patients come in contact with the mold. (Source: FDA MedWatch)
Source: FDA MedWatch - November 15, 2014 Category: American Health Source Type: news

Mayhem: Public Notification - Undeclared Drug Ingredients
Risk of impaired ability to fight infections, high blood sugar levels, muscle injuries, and psychiatric problems. (Source: FDA MedWatch)
Source: FDA MedWatch - November 14, 2014 Category: American Health Source Type: news

Nellcor Puritan Bennett, 980 Ventilator System: Class I Recall - Software Issue May Stop Ventilator
Ventilator may stop working after the air and oxygen gas supply lines are disconnected and then reconnected. This can lead to serious health problems or death. (Source: FDA MedWatch)
Source: FDA MedWatch - November 7, 2014 Category: American Health Source Type: news

GemStar Power Supply, 3VDC for GemStar Infusion Pumps by Hospira: Class I Recall - Power Supply May Not Deliver Enough Electricity
Use of recalled devices may cause serious health risks, including delay in therapy, delivery of too much fluid, too high or too low blood pressure, slow or fast heart rhythm/beat, shock, trauma, 1st or 2nd degree burns, smoke inhalation, problems breathing, stroke, and death. (Source: FDA MedWatch)
Source: FDA MedWatch - November 5, 2014 Category: American Health Source Type: news

V26 Slimming Coffee: Public Notification - Undeclared Drug Ingredient
Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. (Source: FDA MedWatch)
Source: FDA MedWatch - November 5, 2014 Category: American Health Source Type: news

10 Percent Neutral Buffered Formalin by Richard-Allan Scientific: Class I Recall - May Contain Incorrect Concentration of Formalin
Use of this defective Formalin may prevent or delay diagnoses and treatment decisions. (Source: FDA MedWatch)
Source: FDA MedWatch - October 31, 2014 Category: American Health Source Type: news